Moreover, a few more recent studies have shown that upregulation of HMGB1 is associated with shoulder tendon injury/tendinopathy in patients and indicated that it would be a valuable target for tendinopathy management [37–39, 47]. This evidence concerns the gene HMGB1 and disease of the tendon.